Tricks and Tips

Thursday, 18 January 2018

Foot And Ankle Devices Market Technology Overview and Restraint Analysis by 2014-2025

The Global Foot and Ankle Devices Market is expected to reach USD 3.4 billion by 2025, based on a new report by Hexa Reports. The market is expected to observe an exponential growth during the forecast period due to the rising incidence of ankle sprains, hammertoe, bunions, osteoporosis and rheumatoid arthritis.

Ankle fractures are one of the most common types of foot injury. Nearly 170,000 people suffer from ankle fractures per year, which require surgical treatment. It is one of the nine most common fractures. This can be attributed to the relatively small surface area of contact in the ankle and the 1.5 times higher body weight on it at rest & 5.5 times higher forces in case of heavy activity. This makes the long-term viability of ankle joints crucial.

Nearly 50,000 patients are diagnosed with end-stage ankle arthritis per year, wherein the ankle cartilage is worn out, causing painful bone-on-bone contact and disability. These patients are recommended total ankle replacements as opposed to ankle fusion, as it provides higher efficacy, thus driving the market. Favorable reimbursement scenario for joint replacements is one the major contributors to its market growth. Medicare, along with some private insurers, reimburses the procedure.

Further key findings from the study suggest:
• Bracing and support dominated the market in 2016. Increasing application of braces drives the market and has resulted in industry players developing and introducing new products in the market. For instance, in October 2017, Vickers Grant Holdings, LLC launched ATHLETICA with an ankle brace as an introductory product for the brand.
• Aging results in significant changes in the skeletal and neuromuscular systems, leading to arthritis, weak ligament, and ACL tear. Symptomatic and asymptomatic tears affect more than 50% of the geriatric population. This is one of the key drivers attributed to the accelerated growth of soft tissue orthopedic devices.
• Geographically, North America held the largest market share in 2016 and is expected to maintain its position during the forecast period. This large share can be accounted for high adoption rate of new technology and favorable reimbursement scenario.
• The companies are tending toward providing novel products by adopting new technology. In February 2016, Zimmer Biomet received FDA approval for its 3D printed foot-and-ankle implant-Unite3D Bridge Fixation System. The product is perceived to offer greater stability and rigidity due to its integrated structure.
• Some key industry contributors are DePuy Synthes, Zimmer Biomet, Stryker, Integra LifeSciences Corporation, Wright Medical Technology, Inc., Advanced Orthopedic Solutions, Acumed, Bioretec Ltd., and Ossur.

Table of Contents
• Chapter 1 Executive Summary
• Chapter 2 Research Methodology
• Chapter 3 Foot And Ankle Devices Market Variables, Trends & Scope
• Chapter 4 Foot And Ankle Devices :Product Estimates & Trend Analysis
• Chapter 5 Foot And Ankle Devices: Application Estimates & Trend Analysis
• Chapter 6 Foot And Ankle Devices: Regional Estimates & Trend Analysis, by Product and Application
• Chapter 7 Competitive Landscape

For More Details Visit @ Hexa Reports

Drug of Abuse Testing Services Market Growth Prospect, Value Chain Analysis and Forecast by 2014-2025

The Global Drug of Abuse Testing Services Market is expected to reach USD 2.9 billion by 2025, according to a new report by Hexa Reports. Increase in demand for therapy for substance abuse is one of the crucial factors anticipated to boost the market. According to World Drug Report 2016, annually, treatments for drug abuse are accessible to only 17% of the total drug abusers. In North American, Eastern & Southeastern Europe, and Asia, opioid is one of the major drugs of concern.

According to World Drug Report 2016, 1 in every 20 people aged 15 to 64 consumed at least one drug in 2014. More than 29 million people who abuse drugs are estimated to suffer from drug-related disorders. There are 12 million people that abuse drugs, out of whom 14% are suffering from HIV. Cannabis and amphetamine are some of the highly abused drugs globally. Approximately 183 million people used cannabis in 2014. Stringent regulations for drug abuse testing at workplaces, such as Omnibus Transportation Employee Testing Act of 1991, etc., are expected to increase demand for screening kits over the forecast period.

Morbidity and mortality due to drug abuse are rising globally. One in every 4 deaths is attributed to tobacco, alcohol, and illicit drug consumption. The overdose of opioids results in adverse and serious health conditions. In the U.S., the nonmedical use of prescription opioids has considerably increased. According to statistics reported by National Institute of Drug Abuse, overdose of opioids results in more than 90 deaths every day in the U.S. The rise in prevalence of comorbidities associated with substance abuse, such as HIV and hepatitis C, have resulted in increase in demand for screening procedures. Furthermore, increase in the number of government initiatives to control illicit drugs and alcohol usage and rise in number of treatment alternatives are also driving the market.

Further key findings from the report suggest:
• The global drug of abuse testing services market size was estimated at USD 1,465.4 million in 2016 and is expected to grow at a CAGR of 8.1% from 2017 to 2025
• Cannabis emerged as the largest drug type segment and the opioids segment is anticipated to witness fastest growth over the next 8 years
• The North America region accounted for the largest market share in 2016 due to increased usage of medical marijuana, increased usage of investigational testing, and rise in number of toxicology laboratories.
• Asia Pacific is anticipated to witness lucrative growth over the next decade due to increase in alcohol consumption and related disorders in this region
• The market is highly consolidated in the U.S., with Laboratory Corporation of America Holdings; Alere; United States Drug Testing Laboratories, Inc. (USDTL); Quest Diagnostics, Inc. holding 85% market share.

Table of Contents
• Chapter 1 Research Methodology
• Chapter 2 Executive Summary
• Chapter 3 Drug of Abuse Testing Services Market Variables, Trends & Scope
• Chapter 4 Drug of Abuse Testing Services Market: Product Estimates & Trend Analysis
• Chapter 5 Drug of Abuse Testing Services Market: Regional Estimates & Trend Analysis, by Drug Type
• Chapter 6 Competitive Landscape

For More Details Visit @ Hexa Reports

Bioresorbable Coronary Stents Market Development Trends, Economic Impacts and Market Forecasts to 2016-2025

Anticipated as well as recently launched Global Bioresorbable Coronary Stents Market will trigger a revenue increase to USD 247 million by 2025. According to a new report by Hexa Reports, better device attributes of second-generation coronary stents will provide the ascending push to this market.

Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices.Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).

What sets the second-generation bioresorbable coronary stents apart? - Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.

Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.

Further key findings from the study suggest:
• Europe region is the major contributor for the bioresorbable stents market in 2016. Subsequent to withdrawal of the bioresorbable Absorb BVS, emergence of CE-approved bioresorbable stents hold strong growth prospects for greater sales in the member countries.
• APAC follows Europe with almost 30% segment share and is expected to record the fastest growth in the future
• Absorb BVS, among the key brands, engendered the highest sales revenue in 2016, while Absorb 2nd generation device will supersede the sales of its rival devices toward the end of the forecast period
• North America trails behind as the smallest revenue generator against leading counterparts, Europe and APAC, in this market. Downfall of Abbott's Absorb BVS, the only approved FDA device, is the underlying reason for the small segment share in the U.S. region.
• Key players in this space include BIOTRONIK, Meril Lifesciences Pvt. Ltd., Abbott, Elixir Medical Corporation, REVA Medical, Arterial Remodeling Technologies, and Amaranth Medical
• Strategic efforts undertaken by the companies to gain a higher market share center on bioresorbable coronary stents development. Companies targeting the clinical pipeline have developed second-generation bioresorbable products with better design specifications, such as devices with thinner strut thicknesses and faster absorption rates that gain comparability with the gold standard, drug-eluting metallic stents.

For More Details Visit @ Hexa Reports

Collateral Ligament Stabilizer System Market Scope, Overview and Key Vendor Analysis by 2014-2025

The Global Collateral Ligament Stabilizer System Market is expected to reach USD 2.36 billion by 2025, according to a new report by Hexa Reports. Increase in number of sports injuries and road accidents is expected to boost the adoption of Collateral Ligament Stabilizer System (CLSS). According to Stanford Children's Health, around 3.5 million children aged 14 years and below are affected by some form of sport-related injury every year. This shows the potential demand for CLSS in the coming years.

Nearly one-third of all injuries affecting children arise due to sport-related activities. Sports Medicine Australia also estimated that 1 in 17 Australians suffer from sport trauma each year. According to the Zurich American Insurance Company, 62% of the injuries related to organized sports occur during practices. Thus, increasing sports-related injuries has resulted in the high demand for collateral ligament stabilizer systems.

According to WHO, every year nearly 1.25 million people die due to road accidents and about 20 to 50 million are injured. Thus, the rise in number of road accidents is anticipated to heighten the adoption of CLSS.

Furthermore, increasing geriatric population across the globe is another major factor propelling the growth of CLSS market. According to a report published by the U.S. Census Bureau, Japan has the highest percentage of aging population in the world. In 2015, about 26.6% of the population in Japan was aged 65 years and over, which accounted for nearly 33.7 million people.

Further key findings from the study suggest: 
• The medial collateral ligament segment held the dominant share owing to the increase in number of medial collateral ligament trauma resulting from sports or road accidents
• The grade 2 injury segment is anticipated to grow at a lucrative CAGR due to the increase in number of grade 2 injuries and recommendations by medical practitioners to use collateral ligament stabilizer systems in such cases
• On the basis of end use, orthopedic clinics held the largest share of the CLSS market owing to the increase in establishment of specialty clinics and growing preference of patients for such clinics
• Asia Pacific is anticipated to grow at a lucrative CAGR owing to presence of high untapped opportunities, rising prevalence of chronic conditions such as osteoarthritis, and rise in number of accident & trauma cases

For More Details Visit @ Hexa Reports

ECG Equipment and Management System Market Report Guidance for Industry Review and Market Analysis to 2014-2025

The Global ECG Equipment and Management Market is expected to reach USD 7.63 million by 2025, according to a new report by Hexa Reports. Increase in geriatric population across the world coupled with rise in cardiac diseases are likely to drive the market during the forecast period.

Furthermore, increase in investment by various market players and government agencies for development and commercialization of various sensitive and easy-to-use equipment is likely to drive market growth. For instance, in April 2017, CardioComm Solutions, Inc. entered into a conglomerate with CareSpan USA Inc. to incorporate CardioComm's cloud-based ECG analysis tools into CareSpan's Virtual Clinic. This would help in remote analysis of 1, 3, and 12 lead ECG data for online patient care.

In September 2017, the U.S. FDA approved app-driven, easy-to-clean, and fully reusable ECG device manufactured by NimbleHeart. The device wraps around user's torso and is used without electrolytic gels and adhesive. Hence, the device can be cleaned easily, thereby, making the product ideal for multipatient use.

Further Key Findings From the Report Suggest:
• Rising incidence of cardiac diseases and growing geriatric population are expected to propel the growth of the market with a CAGR of 5.8% from 2017 to 2025
• Resting ECG system segment accounted for the highest share of the market and is expected to witness significant growth during the forecast period. This can be attributed to the availability of several commercial products and improved clinical accuracy due to advanced data analysis tools to detect heart related problems.
• Management system segment is witnessed to be the fastest growing segment in the forecast period owing to introduction of innovative products such as mobile access to waveforms, ease of use, and increased efficiency.
• Geographically, North America was the major contributor in the ECG equipment and management market in 2016. It is anticipated to maintain its dominance during the forecast period due to demand for portable monitoring & diagnostic devices, adoption of new technologies, and product launches.
• The market in Asia Pacific is likely to witness significant growth over the next decade owing to increasing investments and entry of key market players in the region, and growing healthcare expenditure and disposable income, in major markets, such as Japan and China.
• Some of the key players are BioTelemetry, Inc.; Compumed Inc.; GE Healthcare; Mindray Medical; Hill Rom; NIHON KOHDEN CORPORATION; Philips Healthcare; Schiller AG; Spacelabs Healthcare; Welch Allyn; CardioComm Solutions, Inc.; McKesson Corporation; Device Technologies; and Meditech.

Table of Contents
• Chapter 1. Methodology and Scope
• Chapter 2. Executive Summary
• Chapter 3. ECG Equipment and Management System Industry Outlook
• Chapter 4. ECG Equipment and Management System Market: Type Outlook
• Chapter 5. ECG Equipment and Management System Market: End-User Outlook
• Chapter 6. ECG Equipment and Management System Market: Regional Outlook
• Chapter 7. Competitive Landscape
• Chapter 8. Company Profiles

For More Details Visit @ Hexa Reports